June 16, 2025
“We continue to invest in the Phoenix platform to support the complex modeling needs of PK/PD scientists who rely on Phoenix for decision making,” said Martin Snyder, President, Data Science Software. “From the first non-compartmental analysis to safety assessment for millions of patients, Phoenix is a critical system throughout drug development.”
“Our Phoenix roadmap over the next year is groundbreaking,” said Snyder . “Our user community has asked for greater control to create, customize, and collaborate on the data visualizations that make up much of the Tables, Listings, and Figures section of submission documents. Later this year, they’ll have that ability with TFL Studio, the first module of the Phoenix Cloud.”
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at www.certara.com.
Certara contact:
Sheila Rocchio
[email protected]
Media contact:
Alyssa Horowitz
[email protected]
You May Also Like